Treasure or artifact: a decade of p63 research speaks for itself.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Delineating Molecular Mechanisms of Squamous Tissue Homeostasis and Neoplasia: Focus on p63.Journal of skin cancer · 2013
   Article
2. ΔNp63 knockout mice reveal its indispensable role as a master regulator of epithelial development and differentiation.Development (Cambridge, England) · 2012
   Article
3. A symphony of regulations centered on p63 to control development of ectoderm-derived structures.Journal of biomedicine & biotechnology · 2011
   Review
4. Brdm2 - an aberrant hypomorphic p63 allele.Cell death and differentiation · 2010
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

5 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as